Regulatory Perspective of Biomarker Bioanalysis During Drug Development
Overview
Authors
Affiliations
Best Practices and Recommendations for Non-Liquid Matrices Bioanalysis.
Vazvaei-Smith F, Li W, Barnaby O, Bhardwaj S, Dong J, Dumont C AAPS J. 2025; 27(2):57.
PMID: 40069400 DOI: 10.1208/s12248-025-01033-w.
IVIVE: Facilitating the Use of Toxicity Data in Risk Assessment and Decision Making.
Chang X, Tan Y, Allen D, Bell S, Brown P, Browning L Toxics. 2022; 10(5).
PMID: 35622645 PMC: 9143724. DOI: 10.3390/toxics10050232.
Mowday A, Copp J, Syddall S, Dubois L, Wang J, Lieuwes N Theranostics. 2020; 10(23):10548-10562.
PMID: 32929365 PMC: 7482819. DOI: 10.7150/thno.46826.